BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15494398)

  • 41. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophenoloxidase-activating proteinase-3 (PAP-3) from Manduca sexta hemolymph: a clip-domain serine proteinase regulated by serpin-1J and serine proteinase homologs.
    Jiang H; Wang Y; Yu XQ; Zhu Y; Kanost M
    Insect Biochem Mol Biol; 2003 Oct; 33(10):1049-60. PubMed ID: 14505699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of recombinant murine cytotoxic cell proteinase-1 requires deletion of an amino-terminal dipeptide.
    Caputo A; Garner RS; Winkler U; Hudig D; Bleackley RC
    J Biol Chem; 1993 Aug; 268(24):17672-5. PubMed ID: 8349649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conversion of the substrate specificity of mouse proteinase granzyme B.
    Caputo A; James MN; Powers JC; Hudig D; Bleackley RC
    Nat Struct Biol; 1994 Jun; 1(6):364-7. PubMed ID: 7664048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and purification of recombinant human granzyme B from Pichia pastoris.
    Sun J; Bird CH; Buzza MS; McKee KE; Whisstock JC; Bird PI
    Biochem Biophys Res Commun; 1999 Aug; 261(2):251-5. PubMed ID: 10425174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of fully active recombinant murine granzyme B in yeast.
    Pham CT; Thomas DA; Mercer JD; Ley TJ
    J Biol Chem; 1998 Jan; 273(3):1629-33. PubMed ID: 9430705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.
    Rotonda J; Garcia-Calvo M; Bull HG; Geissler WM; McKeever BM; Willoughby CA; Thornberry NA; Becker JW
    Chem Biol; 2001 Apr; 8(4):357-68. PubMed ID: 11325591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes).
    Winkler U; Allison NJ; Woodard SL; Gault RA; Ewoldt GR; Kam CM; Abuelyaman A; Powers JC; Hudig D
    Mol Immunol; 1996; 33(7-8):615-23. PubMed ID: 8760273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction between duodenase and alpha1-proteinase inhibitor.
    Gladysheva IP; Popykina NA; Zamolodchikova TS; Larionova NI
    Biochemistry (Mosc); 2001 Jun; 66(6):682-7. PubMed ID: 11421818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterologous expression of human granzyme K in Bacillus subtilis and characterization of its hydrolytic activity in vitro.
    Babé LM; Yoast S; Dreyer M; Schmidt BF
    Biotechnol Appl Biochem; 1998 Apr; 27(2):117-24. PubMed ID: 9569606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A.
    Quan LT; Caputo A; Bleackley RC; Pickup DJ; Salvesen GS
    J Biol Chem; 1995 May; 270(18):10377-9. PubMed ID: 7737968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis.
    Sköld S; Zeberg L; Gullberg U; Olofsson T
    Exp Hematol; 2002 Jul; 30(7):689-96. PubMed ID: 12135665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
    Sathe S; Sakata M; Beaton AR; Sack RA
    Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
    Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
    Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization and expression of a granzyme of an ectothermic vertebrate with chymase-like activity expressed in the cytotoxic cells of Nile tilapia (Oreochromis niloticus).
    Praveen K; Leary JH; Evans DL; Jaso-Friedmann L
    Immunogenetics; 2006 Feb; 58(1):41-55. PubMed ID: 16467988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The primary elastase inhibitor (elastasin) and trypsin inhibitor (contrapsin) in the goat are serpins related to human alpha 1-anti-chymotrypsin.
    Potempa J; Enghild JJ; Travis J
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):191-7. PubMed ID: 7864809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serpin=serine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis.
    Chou SM; Taniguchi A; Wang HS; Festoff BW
    J Neurol Sci; 1998 Oct; 160 Suppl 1():S73-9. PubMed ID: 9851654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties.
    Rao NV; Wehner NG; Marshall BC; Gray WR; Gray BH; Hoidal JR
    J Biol Chem; 1991 May; 266(15):9540-8. PubMed ID: 2033050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity.
    Desrochers PE; Jeffrey JJ; Weiss SJ
    J Clin Invest; 1991 Jun; 87(6):2258-65. PubMed ID: 1645757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.